Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CD40 LIGAND INDUSTRY
2.1 Summary about CD40 Ligand Industry
2.2 CD40 Ligand Market Trends
2.2.1 CD40 Ligand Production & Consumption Trends
2.2.2 CD40 Ligand Demand Structure Trends
2.3 CD40 Ligand Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 ISF-35
4.2.2 LOAd-700
4.2.3 MEDI-4920
4.2.4 MegaCD40L
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hepatitis B
4.3.2 Bladder Cancer
4.3.3 Liver Cancer
4.3.4 Ovarian Cancer
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 ISF-35
5.2.2 LOAd-700
5.2.3 MEDI-4920
5.2.4 MegaCD40L
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hepatitis B
5.3.2 Bladder Cancer
5.3.3 Liver Cancer
5.3.4 Ovarian Cancer
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 ISF-35
6.2.2 LOAd-700
6.2.3 MEDI-4920
6.2.4 MegaCD40L
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hepatitis B
6.3.2 Bladder Cancer
6.3.3 Liver Cancer
6.3.4 Ovarian Cancer
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 ISF-35
7.2.2 LOAd-700
7.2.3 MEDI-4920
7.2.4 MegaCD40L
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hepatitis B
7.3.2 Bladder Cancer
7.3.3 Liver Cancer
7.3.4 Ovarian Cancer
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 ISF-35
8.2.2 LOAd-700
8.2.3 MEDI-4920
8.2.4 MegaCD40L
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hepatitis B
8.3.2 Bladder Cancer
8.3.3 Liver Cancer
8.3.4 Ovarian Cancer
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 ISF-35
9.2.2 LOAd-700
9.2.3 MEDI-4920
9.2.4 MegaCD40L
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hepatitis B
9.3.2 Bladder Cancer
9.3.3 Liver Cancer
9.3.4 Ovarian Cancer
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Biogen, Inc.
10.1.2 Bristol-Myers Squibb Company
10.1.3 eTheRNA Immunotherapies NV
10.1.4 ImmuNext, Inc.
10.1.5 Juno Therapeutics Inc.
10.1.6 MedImmune, LLC
10.1.7 Targovax AS
10.1.8 XL-protein GmbH
10.2 CD40 Ligand Sales Date of Major Players (2017-2020e)
10.2.1 Biogen, Inc.
10.2.2 Bristol-Myers Squibb Company
10.2.3 eTheRNA Immunotherapies NV
10.2.4 ImmuNext, Inc.
10.2.5 Juno Therapeutics Inc.
10.2.6 MedImmune, LLC
10.2.7 Targovax AS
10.2.8 XL-protein GmbH
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
